Skip to main content
. 2021 Jun 11;113(12):1761–1769. doi: 10.1093/jnci/djab116

Figure 1.

Figure 1.

Clinical outcomes by smoking status. A) Distribution of tumor mutation burden (TMB) among never, former, and current smokers were presented. Clinical outcomes of (B) objective response rate (ORR), (C) progression-free survival according to Response Evaluation Criteria In Solid Tumors version 1.1, and (D) overall survival among never, former, and current smokers are presented.